MedTrace Logo

Glaucoma HFA / OCT Specificity Study

NCT02708082 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2016-03-15

No results posted yet for this study

Summary

Study consists of five visits over a one to three month time period.

Conditions

Interventions

DEVICE

OCT scanning and HFA perimetry

Imaging of the optic nerve and nerve fiber layer / measurement of visual field

Sponsors & Collaborators

  • Carl Zeiss Meditec, Inc.

    lead INDUSTRY

Principal Investigators

  • Thomas Callan · Carl Zeiss Meditec, Inc.

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-08-31
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02708082 on ClinicalTrials.gov